For many patients, yes
About the Experts Dan Maselli, M.D., a board-certified internal medicine, gastroenterology, and obesity medicine physician and the associate director of research for True You Weight Loss, a weight loss center in Cary, North Carolina
However, GLP-1 Treatments, Semaglutide or Tirzepatide isn't one of those quick-fix solutions
may be a barrier for some Injection site reactions can occur Weekly injections offer simplicity and better adherence for many, while daily pills suit those uncomfortable with injections but require more routine discipline
When a patient misses a critical dose, alerts are sent to caregivers mobile devices to avoid serious consequences and emergency room visits
Contrave is an FDA-approved combination of bupropion and naltrexone